Programação do Evento

28/02/2026 - Sábado

HorárioTemaPalestrante
08:00 Welcome and Opening remarks
Session 1 - Welcome back!Chair - Higino Steck
08:20 The centimeter mark or the intrathyroidal tumor. What’s the new cornerstone to define low-risk tumors?Michael Tuttle - USA
08:40 Defining the Suspicious Nodule accordingly to the new ATA GuidelinesLaura Boucai - USA
09:00 Personalizing Surgery for DTC: Integrating Theranostic Risk Stratification and Differentiation BiologySeza Goulec - USA
09:20 Q&A
09:30 Debate - Molecular MarkersChair: Evandro Vasconcelos | Debatedores: Maria Cristina Chammas x Mario Araújo Jr.Ricardo Gama (20min) X US and FNAB as decision tools - Cleo Mesa (20min)
10:30 Break
Session 2 - The less aggressive approach to Low riskChair - Simone Dutenhefner
10:50 Any treatment necessary? How much treatment is enough?Erivelto Volpi
11:10 Isthmus carcinomas. Are we facing "the ugly" low-risk PTC?Michael Tuttle - USA
11:30 Nodal surgery in DTC preop assessmentGregory Randolph - USA
11:50 Defining Response to treatment of DTC using Thyroglobulin and Imaging in accordance with the new ATA GuidelinesLaura Boucai - USA
12:10 Q&A
12:15 The Great Debate: Who Really Needs Surgery? (Lunch Session)Chair: JG Vartanian | Moderator: Carolina Ferraz | AS: Alvaro Sanabria - COL x Thermal Ablation: Leonardo Rangel x Surgery: Rafael De Cicco
Session 3 - Who's afraid of Partial Thyroidectomy?Chair - Rafael De Cicco | Moderators: Cleber Camacho x Fernando Walder
14:00 Micro MTC and LobectomyGabrielle Materazzi - ITA
14:20 Lobectomy in "aggressive" variants of papillary carcinomaMichael Tuttle - USA
14:40 Lobectomy in follicular carcinoma and Oncocytic cell carcinomaMichael Yeh - USA
15:00 Revision surgery in DTC - who is a candidate?Gregory Randolph - USA
15:20 Q&A
15:30 Coffee Break
15:50 Chair: Evandro VasconcelosHow Artificial Intelligence is Changing Thyroid Nodule DiagnosticsMichael Yeh - USA
16:20 Bread and butter for Thy Ca follow-upChair: Rafael Scheffel | Moderators: Rui Maciel x Cleo Mesa Jr
16:20 What is the ideal TSH level after lobectomy? Why do we continue to use the same TSH range goal as before?Laura Boucai - USA
16:40 DTC Follow-up Strategy. What Really Matters in Lobectomy?Adriano Cury
17:00 Is there an "exit ramp" of follow-up for the low-risk DTC patient after LobectomyDebora Danilovic

01/03/2026 - Domingo

HorárioTemaPalestrante
Session 1 - Leading the U-turn in helpless casesCo-Chairs: Thiago Bueno, William William
08:00 New medications on the blockAline Lauda
08:20 Bring it back! (the redifferentiation strategy)Fernanda Vaismann
08:40 New approaches for anaplastic thyroid carcinomaAna Hoff
Session 2 - Intermediate Risk or the unexpected future high risk?Chair: Antonio Gonçalves | Debaters: Leonardo Rangel x Renan Lira
09:00 Prognostic factors not to miss the actual Intermediate RiskMichael Yeh - USA
09:20 Situations in which radioactive iodine can be the fundamental adjuvantGeorge Coura
09:40 To what extent is surgical treatment decisive for the patient's cure?Gabrielle Materazzi - ITA
10:00 Clinical follow-up and definition of disease in remissionGlaucia Mazzetto
10:20 Q&A
10:30 Coffee Break
Session 3 - Everyday pitfalls. Small doubts, big decisions.Chair - Carolina Janovsky | Debaters: Dalton Anjos x Susan Chow Lindsey
11:00 What to do about high thyroglobulin levels when no visible disease is presentJuan Pablo Dueñas - COL
11:20 I131 dose less than 100 mCi. Does it still make sense in a world of lobectomies (less-is-more philosophy)?Rosalia Padovani
11:40 The New Era of RAI: Biology- and Dosimetry-Guided Therapy for Differentiated Thyroid CancerSeza Gulec - USA
12:30 Lunch Session
Session 4 - "Thyroidology in concert"Chair: Luiz Paulo Kowalski | Debaters: Juan Pablo Dueñas - COL, Fernanda Vaisman
13:30 Neoadjuvant Therapies in Locally Advanced Invasive DTCGregory Randolph - USA
13:50 Active Surveillance of Cervical Lymph Nodes in Thyroid TumorsRafael Scheffel
14:10 Management of lymph node metastasis with ablative therapiesAntonio Rahal
14:30 Tumor BoardPresenters: Thiago Bueno, Rafael Scheffel, Victor Bandini Vieira, Carolina Janoski, Alvaro Sanabria - COL | Debaters: Rafael De Cicco, Antonio Bertelli, Cleo Mesa, Eduardo Tomimori, Rosalia Padovani, Aline Lauda
RealizaçãoCecatir
OrganizaçãogrowUp
Apoio
SBCSBCSBC

2026. Todos os Direitos Reservados. Thyroid

Logo TOOB